There are too many dreadful provisions in Democrats’ $3.5 trillion spending monstrosity to count, but one is rising to the surface as especially destructive. That would be its prescription drug price-control schemes.
A study by University of Chicago economist Tomas Philipson and analyst Troy Durie concludes that the Congressional Budget Office is wrong by more than an order of magnitude in its estimates of how many new and better drugs would be lost if this legislation were to be enacted. Read more…